Sub Services
Pharmacoeconomic Model Adaptation
Adapting global pharmacoeconomic models to local data and healthcare contexts, ensuring relevancy and accuracy. This involves customizing models to reflect local clinical practices, cost structures, and patient demographics, providing precise evaluations for regulatory submission and market strategies.
Policy Studies for Market Access
Conducting policy studies to facilitate market access by effectively explaining disease, indication, and product value during licensing, pricing, and reimbursement processes. These studies enhance the understanding of the therapeutic landscape, supporting favorable reimbursement decisions and policy development.
Health Data and Information Management
Developing user-friendly database systems and configurable platforms to manage health data efficiently. This service leverages digital health technologies to streamline data collection and analysis, supporting decision-making and healthcare management.
Reimbursement Application Strategy
Crafting strategies for reimbursement applications across different therapeutic areas and preparing comprehensive reimbursement dossiers. This service ensures that applications meet regulatory requirements and effectively demonstrate the value proposition of the product, enhancing the likelihood of positive reimbursement outcomes.
Consultancy on Public-Industry Collaborative Models
Providing consultancy services to develop alternative working models that support reimbursement evaluations and decision-making processes. These models focus on regulatory compliance and mutual benefits for public entities and private companies, fostering innovative collaborations for healthcare improvement.
Expert Opinion and Focus Groups
Conducting expert opinion studies and focus groups to gather insights on local data acquisition, disease prevalence, and market dynamics. These activities provide valuable input for model adaptation and strategic planning, ensuring that HEOR activities are well-informed and impactful.
Social Responsibility Programs for Medicine Access
Designing programs to accelerate patient access to innovative drugs through socially responsible initiatives. These programs prioritize patient needs and aim to remove barriers to accessing necessary treatments, supporting public health objectives.
Training and Education Services
Offering customized training programs on health economics, market access, and outcomes research for pharmaceutical and medical device companies. These services enhance the capacity of organizations to engage in effective HEOR practices and navigate complex market access landscapes.